The Presentation of an Inborn Error of Immunity is Not Always Infection!

| December 21, 2023

The Presentation of an Inborn Error of Immunity is Not Always Infection!

Welcome to Season Two of AllergyTalk! In this season, we are going to introduce you to each of the AllergyWatch assistant editors who work so hard on scouring the literature in allergy and immunology and bring you the most interesting articles in every issue!

Today we are again joined by Dr. Anthony Montanaro from Oregon Health & Science University, and will be reviewing the January-February 2022 issue of AllergyWatch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology.

Make sure you check out the ACAAI Community on DocMatter where we can continue the discussion about these articles!

Articles Reviewed:

Please rate our podcast on iTunes!

Please give us feedback, corrections, and suggestions!
Email feedback to:

Today’s speakers have the following disclosures:

  • Dr. Lee has nothing to disclose
  • Dr. Fineman: Speaker: Takeda; Research: Aimmune, DBV, Biocryst, Novartis
  • Dr. Montanaro: Research: AstraZeneca, Regeneron, Theravance, and Teva

We’re pleased to offer CME credit for this episode of AllergyTalk! Get credit for this episode.

ACAAI presents this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to the procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that may be referenced.